Record #37210
The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
Original paper date
May 8, 2018
Original DOI
Country
Institution
Department of Radiotherapy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland) · Department of Thyroid Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland) · Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland)
Open access
No
Article type
Citation lifecycle
How this paper is being cited
Pre-retraction
13
Same day
0
Post-retraction
3
% post-retraction
18.8%
~3.4 citations/yr before retraction · ~0.7 citations/yr after
— citing papers
Who is still citing this work
Loading…